Speaking at Jefferies Global Healthcare Conference in London

Excited to join this Jefferies Global Healthcare Conference panel next week in London to discuss how investors and operators are approaching biopharma transactions amid uncertainty.

I’ll be joined by leaders from AstraZeneca, Vir Biotechnology, Inc., and Tune Therapeutics for a conversation on how investors and executives are navigating company-building and dealmaking in today’s market.

#JefferiesHealthcare